Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Measurement of Cytogenetic Endpoints in Lymphocytes of Children Diagnosed With Attention Deficit/Hyperactivity Disorder (ADHD) and Treated With Methylphenidate or Adderall

NCT00341029 is registered in ClinicalTrials.gov with National Institute of Environmental Health Sciences (NIEHS) as lead sponsor.

NCT NCT00341029
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00341029 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Measurement of Cytogenetic Endpoints in Lymphocytes of Children Diagnosed With Attention Deficit/Hyperactivity Disorder (ADHD) and Treated With Methylphenidate or Adderall
Lead sponsor
National Institute of Environmental Health Sciences (NIEHS)
Phase
Observational
Overall status
Completed
Start date
December 7, 2005
Completion date
September 30, 2007
Enrollment
84
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adhd, attention deficit hyperactivity disorder